Lisata Therapeutics, Kuva Labs Amend Merger Agreement to Extend Outside Date to July 21

Lisata Therapeutics entered into an amendment to its Agreement and Plan of Merger with Kuva Labs and Kuva Acquisition. The change moves the Outside Date from July 17, 2026 to July 21, 2026, providing a brief extension to finalize the pending tender offer and related merger steps. The amendment is intended to ensure sufficient time to satisfy remaining closing conditions.

Agreement details:

• Agreement type: Amendment to Agreement and Plan of Merger
• Counterparty: Kuva Labs and Kuva Acquisition
• Signed / Effective: Jul 16 2026 / same
• Duration / Termination: Through Jul 21 2026
• Reason: Provide additional time to complete tender offer and merger closing

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.